Roth CH Acquisition IV registered to offer 10 million units priced at $10 each. A unit consists of one share of common stock and one quarter of one redeemable warrant, with whole warrants exercisable at $11.50.
The new SPAC is focused on business services, consumer, healthcare, technology, wellness or sustainability sectors.
Co-CEO Byron Roth has been has been chairman and CEO of Roth Capital Partners since 1998. Co-CEO John Lipman is a partner and managing director of Investment Banking at Craig-Hallum.
Roth CH III raised $100 million in a March IPO and is in a pending merger with QualTek. Roth II is in a pending merger with indie music company Reservoir. The first Roth CH SPAC completed a merger with PureCycle in March.
Roth Capital Partners and Craig-Hallum Capital Group are lead book-running managers of the offering. They have a 45-day option to purchase up to an additional 1.5 million units to cover any over-allotments.
The SPAC intends to apply for a listing on the Nasdaq under ROCGU. Read more.
